通过Mgat4b介导的选择性N-糖化调节黑色素细胞的发育和黑色素瘤的进展
Babita Sharma1,2, Keerthic Aswin1,2, Tanya Jain3
1Council of Scientific and Industrial Research-Institute of Genomics and Integrative Biology, New Delhi 110025, India.
概括
作为N-甘氨酸分支中的关键酶,MGAT4B调节了黑色素细胞迁移和干细胞维护. 它的抑制阻断了黑色素瘤的开始和进展,确定MGAT4B作为黑色素瘤的潜在治疗点.
科学领域:
- 发展生物学 发展生物学
- 癌症生物学 癌症生物学
- 葡萄糖生物学 葡萄糖生物学
背景情况:
- 黑色素细胞发育途径在黑色素瘤期间经常被重新激活.
- 了解这些调节过程对于黑色素瘤治疗至关重要.
- MGAT4B在色素细胞中N-甘氨酸分支中的作用在很大程度上是未被探索的.
研究的目的:
- 研究MGAT4B在黑色素细胞发育和黑色素瘤开始中的作用.
- 为了确定MGAT4B是否是黑色素瘤的可行的治疗点.
主要方法:
- 在斑马鱼中单细胞RNA测序以分析mgat4b破坏.
- 莱克亲和蛋白质组学来识别MGAT4B控制的蛋白质糖化.
- 斑马鱼MAZERATI平台用于模拟BRAF突变黑色素瘤.
- 在体内研究使用小分子抑制复杂N-糖化酶的抑制剂.
主要成果:
- 干扰mgat4b会影响黑色素细胞前体迁移和干细胞池的建立.
- MGAT4B控制了关键黑色细胞蛋白的糖化,如GPNMB,KIT和TYRP1.
- MGAT4B,而不是MGAT4A,通过JUP错位化调节细胞粘附和迁移.
- 在BRAF突变黑色素瘤患者中MGAT4B的升高与生存率较差相关.
- 在斑马鱼黑色素瘤模型中,mgat4b缺乏会阻止瘤的发病.
- 复杂的N-糖化抑制可以阻止早期黑色素瘤的进展.
结论:
- 通过MGAT4B选择性N-甘氨酸分支对于黑色素细胞的发展和黑色素瘤的发病至关重要.
- MGAT4B 是黑色素瘤治疗的一个有前途的治疗点.
- 向复杂的N-糖化酶可能会抑制黑色素瘤的进展.
相关概念视频
01:25Protein Glycosylation
6.8K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
6.8K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:24Oligosaccharide Assembly
2.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.8K
01:05Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K